Determining vulnerability to schizophrenia in methamphetamine psychosis using exploratory eye movements

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Methamphetamine (MAP) psychosis can present with persistent symptoms even after substance withdrawal.
• Identifying individuals with MAP psychosis who are vulnerable to developing schizophrenia is crucial for early intervention.

Purpose of the Study:

• To determine if patients with persistent methamphetamine (MAP) psychosis exhibit a vulnerability to schizophrenia.
• To investigate the relationship between clinical course, functional impairment, and schizophrenia vulnerability markers in MAP psychosis.

Main Methods:

• Forty-eight patients with MAP psychosis were categorized into transient, prolonged, and persistent types based on clinical course.
• Persistent MAP psychosis patients were further divided into moderately and severely socially impaired groups using the Global Assessment Functioning (GAF) scale.
• Exploratory eye movements, a known schizophrenia vulnerability marker, were assessed in MAP psychosis patients, schizophrenia patients, and healthy controls.

Main Results:

• The severely impaired, persistent MAP psychosis group exhibited the lowest responsive search scores, significantly lower than transient MAP psychosis patients and healthy controls.
• The responsive search scores in the severely impaired, persistent MAP psychosis group were comparable to those of schizophrenia patients.
• These findings suggest a shared vulnerability marker between severe persistent MAP psychosis and schizophrenia.

Conclusions:

• A subset of patients with persistent methamphetamine (MAP) psychosis, particularly those with severe social dysfunction, may share a vulnerability to schizophrenia.
• Exploratory eye movement testing could be a valuable tool in differentiating or identifying schizophrenia vulnerability in MAP psychosis patients.